Candriam S.C.A. Standard Biotools Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$5.5 - $7.41 $955,053 - $1.29 Million	-173,646 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$4.35 - $6.35 $629,379 - $918,749	-144,685 Reduced 45.45%	173,646 $1.07 Million
Q4 2020 Jan 22, 2021	BUY	$5.45 - $8.65 $181,653 - $288,313	33,331 Added 11.7%	318,331 $1.91 Million
Q3 2020 Oct 19, 2020	BUY	$4.34 - $11.43 $1.24 Million - $3.26 Million	285,000 New	285,000 $2.12 Million

143

276M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $127M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.